TREATMENT OR REPLACEMENT THERAPY USING TRANSGENIC STEM CELLS DELIVERED TO THE GUT
摘要
The present invention is directed to methods for hormone delivery to patients suffering from a condition associated with a hormone deficiency. The method involves transducing stem cells, such as bone marrow derived stem cells, with a hormone gene under the control of a cell-type specific promoter such as the glucose-responsive GIP promoter, such that the hormone gene is expressed only after the stem cells differentiate into the cells which express the cell-type specific promoter, and administering the stem cells to the patient. A preferred embodiment of the present invention is the use of GIP-insulin gene expression in K cells of the gut to treat diabetes.
申请公布号
WO02096195(A1)
申请公布日期
2002.12.05
申请号
WO2002US17178
申请日期
2002.05.31
申请人
ENTEROMED INC.;WOLFE, M., MICHAEL,;JEPEAL, LISA;BOYLAN, MICHAEL, O.
发明人
WOLFE, M., MICHAEL,;JEPEAL, LISA;BOYLAN, MICHAEL, O.